EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanistic Analysis of Drug Linker Clearance During Ultrafiltration/Diafiltration of an Antibody–Drug Conjugate

Vasudev Tangry, Fara Lyu, Amy Le, Laurie Mlinar, Manish S Kelkar, Andrew L Zydney iD

Biotechnology and Bioengineering · 21.08.2026

DOI: 10.1002/bit.70357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 21.08.2026. Verfasst von Vasudev Tangry und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ultrafiltration/diafiltration (UF/DF) is a key unit operation in the manufacture of antibody‐drug conjugates (ADCs), commonly utilized for post‐conjugation purification to remove residual Drug Linker (DL) compounds and affect buffer exchange. The clearance of residual drug linker (DL), however, is often well below that predicted by ideal diafiltration theory. This work provides the first detailed mechanistic analysis of the factors that influence DL clearance during constant volume diafiltration, with particular emphasis on antibody concentration, membrane properties, and operating conditions. Diafiltration experiments in both stirred cell and tangential flow filtration systems demonstrate that DL sieving coefficients decrease with increasing ADC concentration and with increasing filtrate flux. These trends are quantitatively described using a newly developed diafiltration model accounting for intermolecular association between the hydrophobic DL and the ADC, with the ADC concentration at the membrane surface evaluated using the classical concentration polarization analysis. Experimental data obtained over a range of conditions are well‐described using this concentration polarization‐binding model. The model not only explains DL clearance data, but it also provides a framework for effective process design of UF/DF processes to ensure the required levels of DL clearance during ADC purification.

Schlagwörter

Stichwörter der Autor:innen

antibodyantibody‐drug conjugateclearancediafiltrationultrafiltration

Autor:innen und Institutionen

  • Department of Chemical Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • AbbVie Inc., North Chicago, Illinois, USA.

ORCID-Profile: Andrew L Zydney

Förderung

  • National Science Foundation

Zitieren

APA

Tangry, V., Lyu, F., Le, A., Mlinar, L., Kelkar, M. S., & Zydney, A. L. (2026). Mechanistic Analysis of Drug Linker Clearance During Ultrafiltration/Diafiltration of an Antibody–Drug Conjugate. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70357

Vancouver

Tangry V, Lyu F, Le A, Mlinar L, Kelkar MS, Zydney AL. Mechanistic Analysis of Drug Linker Clearance During Ultrafiltration/Diafiltration of an Antibody–Drug Conjugate. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70357

BibTeX
@article{Tangry2026,
  author = {Tangry, Vasudev and Lyu, Fara and Le, Amy and Mlinar, Laurie and Kelkar, Manish S and Zydney, Andrew L},
  title = {Mechanistic Analysis of Drug Linker Clearance During Ultrafiltration/Diafiltration of an Antibody–Drug Conjugate},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  doi = {10.1002/bit.70357}
}
Kostenlos starten →